Download PDF
Thromb Haemost 1974; 32(02/03): 592-599
DOI: 10.1055/s-0038-1647728
Original Article
Schattauer GmbH

Effects of Thrombolytic Therapy on Hemorrhage from Post-operative Wounds

J. F Cade
1   Departments of Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada
,
D Basu
1   Departments of Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada
,
T. J Muckle
1   Departments of Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada
,
J Hirsh
1   Departments of Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received 18 April 1974

Accepted 20 June 1974

Publication Date:
30 June 2018 (online)

    Permissions and Reprints

Summary

Hemorrhage from post-operative wounds in different organs and structures during thrombolytic therapy was investigated in relation to the time after surgical trauma and to the results of laboratory tests of coagulation and fibrinolysis. Streptokinase was given to rabbits at different times following the production of standardized wounds in different organs. Bleeding was frequent and severe when streptokinase was given between one and five days after surgery and was most marked from artery, followed in order by kidney, vein, liver, muscle, gut and skin. Bleeding appeared to be associated with the in vitro demonstration of an active systemic fibrinolytic state together with elevated levels of fibrin degradation products.

 

  • References

  • 1 Alkjaersig N, Fletcher A. P, Sherry S. 1959; The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38: 1086.
    CrossrefPubMedGoogle Scholar
  • 2 Barritt D. W, Jordan S. C. 1961; Clinical features of pulmonary embolism. Lancet 01: 729.
    PubMedGoogle Scholar
  • 3 Belt T. H. 1934; Thrombosis and pulmonary embolism. American Journal of Pathology 10: 129.
    PubMedGoogle Scholar
  • 4 Btjckell M. 1958; The effect ot citrate on euglobulin methods of estimating fibrinolytic activity. Journal of Clinical Pathology 11: 403.
    CrossrefPubMedGoogle Scholar
  • 5 Dalen J. E, Dexter L. 1969; Pulmonary embolism. Journal of the American Medical Association 207: 1505.
    CrossrefPubMedGoogle Scholar
  • 6 DeTakats G, Jesser J. H. 1940; Pulmonary embolism. Journal of the American Medical Association 114: 1415.
    PubMedGoogle Scholar
  • 7 Fowtler E. F, Bollinger J. A. 1954; Pulmonary embolism: clinical study of 97 fatal cases. Surgery 36: 650.
    PubMedGoogle Scholar
  • 8 Fowler N. O. 1950; Thromboembolism. A survey of the recent literature. Angiology 01: 257.
    PubMedGoogle Scholar
  • 9 Hirsh J, Buchanan M, Glynn M. F, Mustard J. F. 1968; Effect of streptokinase on hemostasis. Blood 32: 726.
    PubMedGoogle Scholar
  • 10 Hirsh J, Cade J. F. 1973. Haemorrhagic disorders and fibrinolysis. In: Birstingl M. (ed.) Peripheral vascular surqery. Heinemann; London: 46.
    Google Scholar
  • 11 Hirsh J, McDonald I. G, Hale G. S. 1970; Streptokinase therapy in acute major pulmonary embolism. American Heart Journal 79: 574.
    PubMedGoogle Scholar
  • 12 Hirsh J, O’Sullivan E. F, Martin M. 1970; Evaluation of a standard dosage schedule with streptokinase. Blood 35: 341.
    PubMedGoogle Scholar
  • 13 Hovig T, Rowsell H. C, Dodds W. J, Jorgensen L, Mustard J. F. 1967; Experimental hemostasis in normal dogs and in dogs with congenital disorders of blood coagulation. Blood 30: 636.
    PubMedGoogle Scholar
  • 14 Hume M, Sevitt S, Thomas D. P. 1970. Venous thrombosis and pulmonary embolism. Harvard; Cambridge.:
    Google Scholar
  • 15 Kakkar V. V, Flanc C, Howe C. T, O’Shea M, Flute P. T. 1969; Treatment of deep vein thrombosis. A trial of heparin, streptokinase and Arvin. British Medical Journal 01: 806.
    PubMedGoogle Scholar
  • 16 Kowalski E, Kopec M, Wegrzynowicz A. 1963; Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thrombosis et Diathesis Haemorrhagica 10: 406.
    PubMedGoogle Scholar
  • 17 Lendrum A. C, Fraser D. S, Slidders W, Henderson R. 1962; Studies on the character and staining of fibrin. Journal of Clinical Pathology 15: 401.
    CrossrefPubMedGoogle Scholar
  • 18 McCartney J. S. 1945; Postoperative pulmonary embolism. Surgery 17: 191.
    PubMedGoogle Scholar
  • 19 Merskey C, Lalezari P, Johnson A. J. 1969; A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proceedings of the Society for Experimental Biology and Medicine 131: 871.
    PubMedGoogle Scholar
  • 20 Morell M. T, Trtjelove S. C, Barr A. 1963; Pulmonary embolism. British Medical Journal 02: 830.
    CrossrefPubMedGoogle Scholar
  • 21 Mustard J. F. 1968; Hemostasis and thrombosis. Seminars in Hematology 05: 91.
    PubMedGoogle Scholar
  • 22 Priestly J. T, Barker N. W. 1942; Postoperative thrombosis and embolism; their treatment with heparin. Surgery Gynecology and Obstetrics 75: 193.
    PubMedGoogle Scholar
  • 23 Salzman E. W, Harris W. H, DeSanctis R. W. 1966; Anticoagulation for prevention of thromboembolism following fractures of the hip. New England Journal of Medicine 275: 122.
    CrossrefPubMedGoogle Scholar
  • 24 Sevitt S, Gallagher N. 1961; Venous thrombosis and pulmonary embolism. British Journal of Surgery 48: 475.
    CrossrefPubMedGoogle Scholar
  • 25 Short D. S. 1952; A survey of pulmonary embolism in a general hospital. British Medical Journal 01: 790.
    CrossrefPubMedGoogle Scholar
  • 26 Towbin A. 1954; Pulmonary embolism. Incidence and significance. Journal of the American Medical Association 156: 209.
    PubMedGoogle Scholar
  • 27 The urokinase pulmonary embolism trial. 1973. Monograph no. 39, American Heart Association; New York.:
    Google Scholar